Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran

1 Jan 2019

Abstract excerpt

BACKGROUND: The therapeutic effect of antiretroviral therapy (ART) is adversely influenced by antiretroviral drug resistance, mainly due to mutations (DRMs) in the human immunodeficiency virus (HIV) genome. These mutations are commonly associated with HIV protease and reverse-transcriptase genes. We sought to determine the frequency of DRMs in a population of ART-experienced patients in the South of Iran. METHOD:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to HIV/AIDS drug development and treatment
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31311021
DOI: 10.1159/000501255

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranPMID 31311021Read ↗

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.Semantic proximity Read ↗

Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014.Semantic proximity Read ↗

HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.Semantic proximity Read ↗

A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 PatientsSemantic proximity Read ↗

Human Immunodeficiency Virus-1 Drug Resistance Mutations in Iranian Treatment-experienced Individuals.Semantic proximity Read ↗

Antiretroviral drug resistance among antiretroviral‐naïve and treatment experienced patients infected with HIV in IranSemantic proximity Read ↗

Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapySemantic proximity Read ↗

Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients.Semantic proximity Read ↗

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.Semantic proximity Read ↗

The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.Semantic proximity Read ↗

HIV antiretroviral resistance mutations among antiretroviral treatment-naive and -experienced patients in South Korea.Semantic proximity Read ↗

Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.